Exchange: NASDAQ·Updated 09:42 AM EDT
MGTX logo

MGTX MeiraGTx Holdings plc

$13.82
$0.01
(0.07%)
Today
Reported EarningsAug 13
Mkt Cap$1.33B
Vol1,709.00

About MGTX

MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It targets local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet needs. The company was founded on March 20, 2015 and is headquartered in New York, NY.
46

Neutral Sentiment

How do you feel about MGTX?

Advertisement|Remove ads.